logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > White to Off-White Crystalline Lisinopril Dihydrate CAS 83915-83-7

White to Off-White Crystalline Lisinopril Dihydrate CAS 83915-83-7

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 83915-83-7

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 83915-83-7 Lisinopril Dihydrate

,

Lisinopril Dihydrate

CAS NO::
83915-83-7
Appearance::
White To Off-white Crystalline Power
Molecular Formula::
C21H31N3O5
Molecular Weight::
405.48800
EINECS NO::
278-488-1
MDL NO::
MFCD00214086
CAS NO::
83915-83-7
Appearance::
White To Off-white Crystalline Power
Molecular Formula::
C21H31N3O5
Molecular Weight::
405.48800
EINECS NO::
278-488-1
MDL NO::
MFCD00214086
White to Off-White Crystalline Lisinopril Dihydrate CAS 83915-83-7

Product Description:

Product Name: Lisinopril Dihydrate CAS NO: 83915-83-7

 

 

Synonyms:

Lisinopril;

(S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline dihydrate;

 

 

Chemical & Physical Properties:

Appearance: White to off-white crystalline power

Assay :≥99.00%

Density: 1.251 g/cm3

Boiling Point: 666.4℃ at 760 mmHg

Melting Point: 160℃ (Decomposes)

Flash Point: 356.9℃

Stability: Stable at normal temperatures and pressures.

Storage Condition: 2-8℃

 

 

Safety Information:

Safety Statements: S22-S24/25

HS Code: 2933990090

Risk Statements: R20/21/22

Hazard Codes: Xi; Xn

 

 

Lisinopril is a drug of the angiotensin-converting enzyme (ACE) inhibitor class used primarily in treatment of high blood pressure, heart failure, and after heart attacks. It is also used for preventing kidney and eye complications in people with diabetes. Its indications, contraindications, and side effects are as those for all ACE inhibitors.

Lisinopril was the third ACE inhibitor (after captopril and enalapril) and was introduced into therapy in the early 1990s. A number of properties distinguish it from other ACE inhibitors: It is hydrophilic, has a long half-life and tissue penetration, and is not metabolized by the liver.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.